Rauvolscin (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Rauvolscin" in Serbian language version.

refsWebsite

Global rank Serbian rank

4^th place

8^th place

2^nd place

4^th place

6^th place

5^th place

1^st place

low place

archive.org

KOHLI JD, DE NN (1956). „Pharmacological action of rauwolscine”. Nature. 177 (4521): 1182. PMID 13334509. doi:10.1038/1771182a0.
Perry BD, U'Prichard DC (1981). „[3H]rauwolscine (alpha-yohimbine): a specific antagonist radioligand for brain alpha 2-adrenergic receptors”. European Journal of Pharmacology. 76 (4): 461—4. PMID 6276200. doi:10.1016/0014-2999(81)90123-0.
Arthur JM, Casañas SJ, Raymond JR (1993). „Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors”. Biochemical Pharmacology. 45 (11): 2337—41. PMID 8517875. doi:10.1016/0006-2952(93)90208-E.
Kaumann AJ (1983). „Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors”. Naunyn-Schmiedeberg's Archives of Pharmacology. 323 (2): 149—54. PMID 6136920. doi:10.1007/BF00634263.
Wainscott DB, Sasso DA, Kursar JD, Baez M, Lucaites VL, Nelson DL (1998). „[3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor”. Naunyn-Schmiedeberg's Archives of Pharmacology. 357 (1): 17—24. PMID 9459568. doi:10.1007/PL00005133. Архивирано из оригинала 11. 09. 2001. г. Приступљено 18. 08. 2012.

KOHLI JD, DE NN (1956). „Pharmacological action of rauwolscine”. Nature. 177 (4521): 1182. PMID 13334509. doi:10.1038/1771182a0.
Perry BD, U'Prichard DC (1981). „[3H]rauwolscine (alpha-yohimbine): a specific antagonist radioligand for brain alpha 2-adrenergic receptors”. European Journal of Pharmacology. 76 (4): 461—4. PMID 6276200. doi:10.1016/0014-2999(81)90123-0.
Arthur JM, Casañas SJ, Raymond JR (1993). „Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors”. Biochemical Pharmacology. 45 (11): 2337—41. PMID 8517875. doi:10.1016/0006-2952(93)90208-E.
Kaumann AJ (1983). „Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors”. Naunyn-Schmiedeberg's Archives of Pharmacology. 323 (2): 149—54. PMID 6136920. doi:10.1007/BF00634263.
Wainscott DB, Sasso DA, Kursar JD, Baez M, Lucaites VL, Nelson DL (1998). „[3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor”. Naunyn-Schmiedeberg's Archives of Pharmacology. 357 (1): 17—24. PMID 9459568. doi:10.1007/PL00005133. Архивирано из оригинала 11. 09. 2001. г. Приступљено 18. 08. 2012.

Wainscott DB, Sasso DA, Kursar JD, Baez M, Lucaites VL, Nelson DL (1998). „[3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor”. Naunyn-Schmiedeberg's Archives of Pharmacology. 357 (1): 17—24. PMID 9459568. doi:10.1007/PL00005133. Архивирано из оригинала 11. 09. 2001. г. Приступљено 18. 08. 2012.

Wainscott DB, Sasso DA, Kursar JD, Baez M, Lucaites VL, Nelson DL (1998). „[3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor”. Naunyn-Schmiedeberg's Archives of Pharmacology. 357 (1): 17—24. PMID 9459568. doi:10.1007/PL00005133. Архивирано из оригинала 11. 09. 2001. г. Приступљено 18. 08. 2012.